These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 10806592)
21. [Ascitic fluid puncture in the treatment of severe forms of ovarian hyperstimulation syndrome]. Machac S; Dostál J; Oborná I; Zahradnícková V; Brezinová J; Labanová M; Kudela M Ceska Gynekol; 2001 Sep; 66(5):333-6. PubMed ID: 11732230 [TBL] [Abstract][Full Text] [Related]
22. Variations in serum vascular endothelial growth factor binding profiles and the development of ovarian hyperstimulation syndrome. McElhinney B; Ardill J; Caldwell C; Lloyd F; McClure N Fertil Steril; 2002 Aug; 78(2):286-90. PubMed ID: 12137864 [TBL] [Abstract][Full Text] [Related]
23. A rise of the serum level of von Willebrand factor occurs before clinical manifestation of the severe form of ovarian hyperstimulation syndrome. Ogawa S; Minakami H; Araki S; Ohno T; Motoyama M; Shibahara H; Sato I J Assist Reprod Genet; 2001 Feb; 18(2):114-9. PubMed ID: 11285978 [TBL] [Abstract][Full Text] [Related]
24. Autologous protein reinfusion in severe ovary hyperstimulation syndrome. Splendiani G; Mazzarella V; Tozzo C; Elli M; Casciani CU J Am Coll Surg; 1994 Jul; 179(1):25-8. PubMed ID: 8019720 [TBL] [Abstract][Full Text] [Related]
25. Severe ovarian hyperstimulation syndrome: serum and ascitic fluid concentrations of vascular endothelial growth factor. Agrawal R; Chimusoro K; Payne N; van der Spuy Z; Jacobs HS Curr Opin Obstet Gynecol; 1997 Apr; 9(2):141-4. PubMed ID: 9204237 [No Abstract] [Full Text] [Related]
27. Follicular fluid levels of vascular endothelial growth factor. Are they predictive markers for ovarian hyperstimulation syndrome? Geva E; Amit A; Lessing JB; Lerner-Geva L; Daniel Y; Yovel I; Azem F; Barak V J Reprod Med; 1999 Feb; 44(2):91-6. PubMed ID: 10853438 [TBL] [Abstract][Full Text] [Related]
28. Ovarian hyperstimulation syndrome and assisted reproductive technologies: why some and not others? McElhinney B; Ardill J; Caldwell C; Lloyd F; McClure N Hum Reprod; 2002 Jun; 17(6):1548-53. PubMed ID: 12042276 [TBL] [Abstract][Full Text] [Related]
29. Ovarian hyperstimulation syndrome: pre-ovulatory serum concentrations of interleukin-6, interleukin-1 receptor antagonist and tumour necrosis factor-alpha cannot predict its occurrence. Loret de Mola JR; Baumgardner GP; Goldfarb JM; Friedlander MA Hum Reprod; 1996 Jul; 11(7):1377-80. PubMed ID: 8671470 [TBL] [Abstract][Full Text] [Related]
30. Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program. Artini PG; Fasciani A; Monti M; Luisi S; D'Ambrogio G; Genazzani AR Fertil Steril; 1998 Sep; 70(3):560-4. PubMed ID: 9757891 [TBL] [Abstract][Full Text] [Related]
31. Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration. Ludwig M; Jelkmann W; Bauer O; Diedrich K Hum Reprod; 1999 Oct; 14(10):2437-41. PubMed ID: 10527964 [TBL] [Abstract][Full Text] [Related]
33. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor. Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240 [TBL] [Abstract][Full Text] [Related]
34. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Abramov Y; Anteby SO; Fasouliotis SJ; Barak V Am J Obstet Gynecol; 2001 Feb; 184(3):354-5. PubMed ID: 11228486 [TBL] [Abstract][Full Text] [Related]
35. Serum vascular endothelial growth factor levels before starting gonadotropin treatment in women who have developed moderate forms of ovarian hyperstimulation syndrome. D'Ambrogio G; Fasciani A; Monti M; Cattani R; Genazzani AR; Artini PG Gynecol Endocrinol; 1999 Oct; 13(5):311-5. PubMed ID: 10599547 [TBL] [Abstract][Full Text] [Related]
36. Markedly elevated cytokines in pleural effusion during the ovarian hyperstimulation syndrome: transudate or ascites? Loret de Mola JR; Arredondo-Soberon F; Randle CP; Tureck RT; Friedlander MA Fertil Steril; 1997 Apr; 67(4):780-2. PubMed ID: 9093211 [TBL] [Abstract][Full Text] [Related]
37. Elevated levels of interleukin-6 in ascites and serum from women with ovarian hyperstimulation syndrome. Friedlander MA; Loret de Mola JR; Goldfarb JM Fertil Steril; 1993 Nov; 60(5):826-33. PubMed ID: 8224268 [TBL] [Abstract][Full Text] [Related]
38. Elevated interleukin-10 and sex steroid levels in peritoneal fluid of patients with ovarian hyperstimulation syndrome. Manolopoulos K; Lang U; Gips H; Braems GA Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 99(2):226-31. PubMed ID: 11788177 [TBL] [Abstract][Full Text] [Related]
39. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647 [TBL] [Abstract][Full Text] [Related]
40. [Preliminary study on the role of vascular endothelial growth factor in pathogenesis of ovarian hyperstimulation syndrome]. Zhou C; Yu C; Zhuang G Zhonghua Fu Chan Ke Za Zhi; 2001 Nov; 36(11):654-6. PubMed ID: 11930688 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]